×

Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use

  • US 8,178,576 B2
  • Filed: 06/03/2008
  • Issued: 05/15/2012
  • Est. Priority Date: 07/15/2002
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method of delivering an ophthalmically acceptable drug to the eye comprising the steps of(a) preparing an intraocular implant composition comprising a lipophilic compound having a molecular weight of 150-4000 and a pharmaceutically effective amount of a drug, but lacking a polymeric ingredient and an organic solvent that is miscible with or dispersible in water, wherein the composition is solid or semi-solid at a temperature of 37°

  • C. or less and the lipophilic compound is of the formula

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×